References
- Coutts R. T., Foster B. C., Jones G. R., Myers G. E. Metabolism of N‐(n‐propyl)amphetamine by, Cunninghamella echinulata. Applied and Environmental Microbiology 1979; 37: 429–432
- Eichelbaum M. Defective oxidation of drugs: Pharmacokinetic and therapeutic implications. Clinical Pharmacokinetics 1982; 7: 1–22
- Ferris J. P., MacDonald M. A., Martin M. A. Aryl hydrocarbon hydrolase activity in the fungus Cunninghamella bainieri, evidence for the presence of cytochrome P‐450. Archives of Biochemistry and Biophysics 1976; 175: 443–452
- Foster B. C., Coutts R. T., Pasutto F. M., Mozayai A. Microbial metabolism of phenelzine and pheniprazine. Life Sciences 1988; 42: 285–292
- McKay G., Cooper J. K., Hawes E. M., Roy S. D., Midha K. K. Identification of new secondary metabolites of methoxyphenamine in man. Xenobiotica 1983; 13: 257–264
- Midha K. K., Cooper J. K., McGilveray I. J., Coutts R. T., Dawe R. Metabolism of methoxyphenamine in man and in monkey. Drug Metabolism and Disposition 1976; 4: 568–576
- Midha K. K., Hawes E. M., Cooper J. K., Hubbard J. W., Bailey K., McGilveray I. J. The identification of two new urinary metabolites of fenfluramine in man. Xenobiotica 1983; 13: 1–38
- Otton S. V., Brinn R. U., Gram L. F. In vitro, evidence against the oxidation of quinidine by the sparteine/debrisoquine monooxygenase of human liver. Drug Metabolism and Disposition 1988; 16: 15–17
- Roy S. D., Hawes E. M., Hubbard J. W., McKay G., Midha K. K. Methoxyphenamine and dextromethorphan as safe probes for debrisoquine hydroxylation polymorphism. Lancet 1984a; 2(8416)1393
- Roy S. D., McKay G., Hawes E. M., Midha K. K. Gas chromatographic quantitation of methoxyphenamine and three of its metabolites in plasma. Journal of Chromatography 1984; 310: 307–317
- Roy S. D., Hawes E. M., McKay G., Hubbard J. W., Midha K. K. Methoxyphenamine metabolism in rat models of human debrisoquine phenotypes. Canadian Journal of Physiology and Pharmacology 1985; 63: 778–781
- Smith R. L. Polymorphism in drug metabolism‐implications for drug toxicity. Archives of Toxicology, Supplement 1986; 9: 138–146
- Smith R. V., Rosazza J. P. Microbial models of mammalian metabolism. Journal of Pharmaceutical Sciences 1975; 64: 1737–1759
- Smith R. V., Rosazza J. P. Microbial models of mammalian metabolism. Journal of Natural Products 1983; 46: 79–91
- Yesell E. S. Selection of subjects for investigation of host factors affecting drug response: a method to identify new pharmacogenetic conditions. Clinical Pharmacology and Therapeutics 1977; 22: 650–679